Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001312663 | SCV001503126 | uncertain significance | Bardet-Biedl syndrome; McKusick-Kaufman syndrome | 2022-05-06 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 297 of the MKKS protein (p.Ile297Thr). This variant is present in population databases (rs147704542, gnomAD 0.006%). This missense change has been observed in individual(s) with Bardet-Biedl syndrome (PMID: 20177705, 30718709). ClinVar contains an entry for this variant (Variation ID: 636042). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV003472325 | SCV004194901 | pathogenic | Bardet-Biedl syndrome 6 | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005029449 | SCV005663386 | uncertain significance | McKusick-Kaufman syndrome; Bardet-Biedl syndrome 6 | 2024-06-10 | criteria provided, single submitter | clinical testing | |
Department of Clinical Genetics, |
RCV000787622 | SCV000926606 | uncertain significance | Bardet-Biedl syndrome | 2018-04-01 | no assertion criteria provided | research |